These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23973340)

  • 1. Driving external chemistry optimization via operations management principles.
    Bi FC; Frost HN; Ling X; Perry DA; Sakata SK; Bailey S; Fobian YM; Sloan L; Wood A
    Drug Discov Today; 2014 Mar; 19(3):289-94. PubMed ID: 23973340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The paradox of scientific excellence and the search for productivity in pharmaceutical research and development.
    Grasela TH; Slusser R
    Clin Pharmacol Ther; 2014 May; 95(5):521-7. PubMed ID: 24458012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound management beyond efficiency.
    Burr I; Winchester T; Keighley W; Sewing A
    J Biomol Screen; 2009 Jun; 14(5):485-91. PubMed ID: 19502566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accessing external innovation in drug discovery and development.
    Tufféry P
    Expert Opin Drug Discov; 2015 Jun; 10(6):579-89. PubMed ID: 25910932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative analysis of quality management standards for contract research organisations in clinical trials.
    Murray E; McAdam R
    Int J Health Care Qual Assur; 2007; 20(1):16-33. PubMed ID: 18240505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug discovery chemistry: a primer for the non-specialist.
    Jordan AM; Roughley SD
    Drug Discov Today; 2009 Aug; 14(15-16):731-44. PubMed ID: 19416759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finding the sweet spot: the role of nature and nurture in medicinal chemistry.
    Hann MM; Keserü GM
    Nat Rev Drug Discov; 2012 Apr; 11(5):355-65. PubMed ID: 22543468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creativity, innovation and lean sigma: a controversial combination?
    Johnstone C; Pairaudeau G; Pettersson JA
    Drug Discov Today; 2011 Jan; 16(1-2):50-7. PubMed ID: 21094693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing the use of CROs by academia and small companies.
    Lane RF; Friedman LG; Keith C; Braithwaite SP; Frearson JA; Lowe DA; Longo FM; Refolo LM; Watterson DM; Tsaioun K; Shineman DW; Fillit HM
    Nat Rev Drug Discov; 2013 Jul; 12(7):487-8. PubMed ID: 23812255
    [No Abstract]   [Full Text] [Related]  

  • 10. The Drug Discovery Portal: a resource to enhance drug discovery from academia.
    Clark RL; Johnston BF; Mackay SP; Breslin CJ; Robertson MN; Harvey AL
    Drug Discov Today; 2010 Aug; 15(15-16):679-83. PubMed ID: 20547242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ask the experts: the challenges and benefits of flow chemistry to optimize drug development.
    Anderson N; Gernaey KV; Jamison TF; Kircher M; Wiles C; Leadbeater NE; Sandford G; Richardson P
    Future Med Chem; 2012 Sep; 4(14):1779-89. PubMed ID: 23043475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient and effective compound management to support lead optimization.
    Johnson CW; Chatterjee M; Kubala S; Helm D; Houston J; Banks M
    J Biomol Screen; 2009 Jun; 14(5):523-30. PubMed ID: 19483145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality by design in lead optimization: a new strategy to address productivity in drug discovery.
    Rossi T; Braggio S
    Curr Opin Pharmacol; 2011 Oct; 11(5):515-20. PubMed ID: 21652263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovation leading the way: application of lean manufacturing to sample management.
    Allen M; Wigglesworth MJ
    J Biomol Screen; 2009 Jun; 14(5):515-22. PubMed ID: 19483142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contract Research Organizations (CROs) in China: integrating Chinese research and development capabilities for global drug innovation.
    Shi YZ; Hu H; Wang C
    Global Health; 2014 Nov; 10():78. PubMed ID: 25406839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case study of lean drug discovery: from project driven research to innovation studios and process factories.
    Ullman F; Boutellier R
    Drug Discov Today; 2008 Jun; 13(11-12):543-50. PubMed ID: 18549982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-centered drug discovery as the means to improved R&D productivity.
    Raoof AA; Aerssens J
    Drug Discov Today; 2015 Sep; 20(9):1044-8. PubMed ID: 25908579
    [No Abstract]   [Full Text] [Related]  

  • 18. Helping science to succeed: improving processes in R&D.
    Sewing A; Winchester T; Carnell P; Hampton D; Keighley W
    Drug Discov Today; 2008 Mar; 13(5-6):227-33. PubMed ID: 18342798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development speed paradox: can increasing development speed reduce R&D productivity?
    Lendrem DW; Lendrem BC
    Drug Discov Today; 2014 Mar; 19(3):209-14. PubMed ID: 24051396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the most important approach in current drug discovery: doing the right things or doing things right?
    Elebring T; Gill A; Plowright AT
    Drug Discov Today; 2012 Nov; 17(21-22):1166-9. PubMed ID: 22569181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.